An integrative model of cellular states, plasticity, and genetics for glioblastoma C Neftel, J Laffy, MG Filbin, T Hara, ME Shore, GJ Rahme, AR Richman, ... Cell 178 (4), 835-849. e21, 2019 | 1781 | 2019 |
Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets PK Brastianos, SL Carter, S Santagata, DP Cahill, A Taylor-Weiner, ... Cancer discovery 5 (11), 1164-1177, 2015 | 1020 | 2015 |
Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq AS Venteicher, I Tirosh, C Hebert, K Yizhak, C Neftel, MG Filbin, ... Science 355 (6332), eaai8478, 2017 | 877 | 2017 |
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations PK Brastianos, PM Horowitz, S Santagata, RT Jones, A McKenna, G Getz, ... Nature genetics 45 (3), 285-289, 2013 | 686 | 2013 |
Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas PK Brastianos, A Taylor-Weiner, PE Manley, RT Jones, D Dias-Santagata, ... Nature genetics 46 (2), 161-165, 2014 | 464 | 2014 |
Longitudinal molecular trajectories of diffuse glioma in adults FP Barthel, KC Johnson, FS Varn, AD Moskalik, G Tanner, E Kocakavuk, ... Nature 576 (7785), 112-120, 2019 | 417 | 2019 |
Analysis of tumour-and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S L Sevenich, RL Bowman, SD Mason, DF Quail, F Rapaport, BT Elie, ... Nature cell biology 16 (9), 876-888, 2014 | 381 | 2014 |
Treatment for brain metastases: ASCO-SNO-ASTRO guideline MA Vogelbaum, PD Brown, H Messersmith, PK Brastianos, S Burri, ... Neuro-oncology 24 (3), 331-357, 2022 | 378 | 2022 |
Pervasive chromosomal instability and karyotype order in tumour evolution TBK Watkins, EL Lim, M Petkovic, S Elizalde, NJ Birkbak, GA Wilson, ... Nature 587 (7832), 126-132, 2020 | 294 | 2020 |
Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma M Abedalthagafi, WL Bi, AA Aizer, PH Merrill, R Brewster, PK Agarwalla, ... Neuro-oncology 18 (5), 649-655, 2016 | 283 | 2016 |
Brain metastasis A Boire, PK Brastianos, L Garzia, M Valiente Nature Reviews Cancer 20 (1), 4-11, 2020 | 281 | 2020 |
Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis ND Mathewson, O Ashenberg, I Tirosh, S Gritsch, EM Perez, S Marx, ... Cell 184 (5), 1281-1298. e26, 2021 | 268 | 2021 |
The evolving landscape of brain metastasis M Valiente, MS Ahluwalia, A Boire, PK Brastianos, SB Goldberg, EQ Lee, ... Trends in cancer 4 (3), 176-196, 2018 | 236 | 2018 |
Leptomeningeal metastasis from systemic cancer: review and update on management N Wang, MS Bertalan, PK Brastianos Cancer 124 (1), 21-35, 2018 | 234 | 2018 |
Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1 LA Ramkissoon, PM Horowitz, JM Craig, SH Ramkissoon, BE Rich, ... Proceedings of the National Academy of Sciences 110 (20), 8188-8193, 2013 | 232 | 2013 |
Dramatic response of BRAF V600E mutant papillary craniopharyngioma to targeted therapy PK Brastianos, GM Shankar, CM Gill, A Taylor-Weiner, N Nayyar, ... Journal of the National Cancer Institute 108 (2), djv310, 2016 | 226 | 2016 |
Tuberculosis-associated haemophagocytic syndrome PK Brastianos, JW Swanson, M Torbenson, J Sperati, PC Karakousis The Lancet infectious diseases 6 (7), 447-454, 2006 | 219 | 2006 |
Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma DJH Shih, N Nayyar, I Bihun, I Dagogo-Jack, CM Gill, E Aquilanti, ... Nature genetics 52 (4), 371-377, 2020 | 217 | 2020 |
Advances in meningioma genetics: novel therapeutic opportunities M Preusser, PK Brastianos, C Mawrin Nature Reviews Neurology 14 (2), 106-115, 2018 | 197 | 2018 |
Alectinib salvages CNS relapses in ALK-positive lung cancer patients previously treated with crizotinib and ceritinib JF Gainor, CA Sherman, K Willoughby, J Logan, E Kennedy, ... Journal of Thoracic Oncology 10 (2), 232-236, 2015 | 193 | 2015 |